In addition, the G12D (glycine 12 to aspartic acid) and G12V (glycine 12 to valine) constitute the most common subtypes of CRC while G12C mutations account for only 7% of KRAS mutations (about 3% of CRC patients) [19]. Here, KRAS is linked to colorectal carcinoma.